 Global Autoimmune Drugs Market 2026-2030
Global Autoimmune Drugs Market 2026-2030 The global autoimmune drugs market is forecasted to grow by USD 38227.2 mn during 2025-2030, accelerating at a CAGR of 6.9% during the forecast period. The... もっと見る
SummaryGlobal Autoimmune Drugs Market 2026-2030The global autoimmune drugs market is forecasted to grow by USD 38227.2 mn during 2025-2030, accelerating at a CAGR of 6.9% during the forecast period. The report on the global autoimmune drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of autoimmune disorders and increased diagnostic capabilities, transition toward precision-targeted biologics and advanced monoclonal antibodies, proliferation of biosimilars and favorable regulatory frameworks. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data. For further information on this report, please visit - Technavio's global autoimmune drugs market is segmented as below: By Therapy Area • Rheumatoid arthritis • Multiple sclerosis • Psoriasis • Inflammatory bowel disease • Others By Distribution Channel • Hospital • Pharmacy • Retail pharmacy • Online By Route Of Administration • Injectable • Oral • Topical By Drug Class • Biologics and biosimilars • Small molecules and JAK inhibitors • Immunosuppressants • Corticosteroids and NSAIDs • Interferons Geography • North America • US • Canada • Mexico • Europe • Germany • UK • France • Italy • Spain • The Netherlands • Asia • Rest of World (ROW) • Rest of World (ROW) This study identifies the integration of ai and ml in drug discovery as one of the prime reasons driving the global autoimmune drugs market growth during the next few years. Also, expansion of subcutaneous delivery systems and self-administered formulations and accelerated penetration of biosimilars across emerging and developed geographies will lead to sizable demand in the market. The report on the global autoimmune drugs market covers the following areas: • Global autoimmune drugs market sizing • Global autoimmune drugs market forecast • Global autoimmune drugs market industry analysis The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global autoimmune drugs market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bausch Health Co Inc., Bayer AG, Biogen Inc., Bristol Myers Squibb Co., Celltrion Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Incyte Corp., Johnson and Johnson, LEO Pharma AS, Merck KGaA, Novartis AG, Organon and Co., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Takeda Pharmaceutical Ltd., UCB SA. Also, the global autoimmune drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities. The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth. Table of Contents1 Executive Summary1.1 Market overview • Executive Summary - Chart on Market Overview • Executive Summary - Data Table on Market Overview • Executive Summary - Chart on Global Market Characteristics • Executive Summary - Chart on Market by Geography • Executive Summary - Chart on Market Segmentation by Therapy Area • Executive Summary - Chart on Market Segmentation by Distribution Channel • Executive Summary - Chart on Market Segmentation by Route of Administration • Executive Summary - Chart on Market Segmentation by Drug Class • Executive Summary - Chart on Incremental Growth • Executive Summary - Data Table on Incremental Growth • Executive Summary - Chart on Company Market Positioning 2 Technavio Analysis 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria 2.2 Criticality of inputs and Factors of differentiation • Chart on Overview on criticality of inputs and factors of differentiation 2.3 Factors of disruption • Chart on Overview on factors of disruption 2.4 Impact of drivers and challenges • Chart on Impact of drivers and challenges in 2025 and 2030 3 Market Landscape 3.1 Market ecosystem • Chart on Parent Market • Data Table on - Parent Market 3.2 Market characteristics • Chart on Market characteristics analysis 3.3 Value chain analysis • Chart on Value chain analysis 4 Market Sizing 4.1 Market definition • Data Table on Offerings of companies included in the market definition 4.2 Market segment analysis • Market segments 4.3 Market size 2025 4.4 Market outlook: Forecast for 2025-2030 • Chart on Global - Market size and forecast 2025-2030 ($ million) • Data Table on Global - Market size and forecast 2025-2030 ($ million) • Chart on Global Market: Year-over-year growth 2025-2030 (%) • Data Table on Global Market: Year-over-year growth 2025-2030 (%) 5 Historic Market Size 5.1 Global Autoimmune Drugs Market 2020 - 2024 • Historic Market Size - Data Table on Global Autoimmune Drugs Market 2020 - 2024 ($ million) 5.2 Therapy Area segment analysis 2020 - 2024 • Historic Market Size - Therapy Area Segment 2020 - 2024 ($ million) 5.3 Distribution Channel segment analysis 2020 - 2024 • Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million) 5.4 Route of Administration segment analysis 2020 - 2024 • Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million) 5.5 Drug Class segment analysis 2020 - 2024 • Historic Market Size - Drug Class Segment 2020 - 2024 ($ million) 5.6 Geography segment analysis 2020 - 2024 • Historic Market Size - Geography Segment 2020 - 2024 ($ million) 5.7 Country segment analysis 2020 - 2024 • Historic Market Size - Country Segment 2020 - 2024 ($ million) 6 Qualitative Analysis 6.1 Impact of AI on global autoimmune drugs market 6.2 Impact of geopolitical conflicts on global autoimmune drugs market 7 Five Forces Analysis 7.1 Five forces summary • Five forces analysis - Comparison between 2025 and 2030 7.2 Bargaining power of buyers • Bargaining power of buyers - Impact of key factors 2025 and 2030 7.3 Bargaining power of suppliers • Bargaining power of suppliers - Impact of key factors in 2025 and 2030 7.4 Threat of new entrants • Threat of new entrants - Impact of key factors in 2025 and 2030 7.5 Threat of substitutes • Threat of substitutes - Impact of key factors in 2025 and 2030 7.6 Threat of rivalry • Threat of rivalry - Impact of key factors in 2025 and 2030 7.7 Market condition • Chart on Market condition - Five forces 2025 and 2030 8 Market Segmentation by Therapy Area 8.1 Market segments • Chart on Therapy Area - Market share 2025-2030 (%) • Data Table on Therapy Area - Market share 2025-2030 (%) 8.2 Comparison by Therapy Area • Chart on Comparison by Therapy Area • Data Table on Comparison by Therapy Area 8.3 Rheumatoid arthritis - Market size and forecast 2025-2030 • Chart on Rheumatoid arthritis - Market size and forecast 2025-2030 ($ million) • Data Table on Rheumatoid arthritis - Market size and forecast 2025-2030 ($ million) • Chart on Rheumatoid arthritis - Year-over-year growth 2025-2030 (%) • Data Table on Rheumatoid arthritis - Year-over-year growth 2025-2030 (%) 8.4 Multiple sclerosis - Market size and forecast 2025-2030 • Chart on Multiple sclerosis - Market size and forecast 2025-2030 ($ million) • Data Table on Multiple sclerosis - Market size and forecast 2025-2030 ($ million) • Chart on Multiple sclerosis - Year-over-year growth 2025-2030 (%) • Data Table on Multiple sclerosis - Year-over-year growth 2025-2030 (%) 8.5 Psoriasis - Market size and forecast 2025-2030 • Chart on Psoriasis - Market size and forecast 2025-2030 ($ million) • Data Table on Psoriasis - Market size and forecast 2025-2030 ($ million) • Chart on Psoriasis - Year-over-year growth 2025-2030 (%) • Data Table on Psoriasis - Year-over-year growth 2025-2030 (%) 8.6 Inflammatory bowel disease - Market size and forecast 2025-2030 • Chart on Inflammatory bowel disease - Market size and forecast 2025-2030 ($ million) • Data Table on Inflammatory bowel disease - Market size and forecast 2025-2030 ($ million) • Chart on Inflammatory bowel disease - Year-over-year growth 2025-2030 (%) • Data Table on Inflammatory bowel disease - Year-over-year growth 2025-2030 (%) 8.7 Others - Market size and forecast 2025-2030 • Chart on Others - Market size and forecast 2025-2030 ($ million) • Data Table on Others - Market size and forecast 2025-2030 ($ million) • Chart on Others - Year-over-year growth 2025-2030 (%) • Data Table on Others - Year-over-year growth 2025-2030 (%) 8.8 Market opportunity by Therapy Area • Market opportunity by Therapy Area ($ million) • Data Table on Market opportunity by Therapy Area ($ million) 9 Market Segmentation by Distribution Channel 9.1 Market segments • Chart on Distribution Channel - Market share 2025-2030 (%) • Data Table on Distribution Channel - Market share 2025-2030 (%) 9.2 Comparison by Distribution Channel • Chart on Comparison by Distribution Channel • Data Table on Comparison by Distribution Channel 9.3 Hospital - Market size and forecast 2025-2030 • Chart on Hospital - Market size and forecast 2025-2030 ($ million) • Data Table on Hospital - Market size and forecast 2025-2030 ($ million) • Chart on Hospital - Year-over-year growth 2025-2030 (%) • Data Table on Hospital - Year-over-year growth 2025-2030 (%) 9.4 Pharmacy - Market size and forecast 2025-2030 • Chart on Pharmacy - Market size and forecast 2025-2030 ($ million) • Data Table on Pharmacy - Market size and forecast 2025-2030 ($ million) • Chart on Pharmacy - Year-over-year growth 2025-2030 (%) • Data Table on Pharmacy - Year-over-year growth 2025-2030 (%) 9.5 Retail pharmacy - Market size and forecast 2025-2030 • Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million) • Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million) • Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%) • Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%) 9.6 Online - Market size and forecast 2025-2030 • Chart on Online - Market size and forecast 2025-2030 ($ million) • Data Table on Online - Market size and forecast 2025-2030 ($ million) • Chart on Online - Year-over-year growth 2025-2030 (%) • Data Table on Online - Year-over-year growth 2025-2030 (%) 9.7 Market opportunity by Distribution Channel • Market opportunity by Distribution Channel ($ million) • Data Table on Market opportunity by Distribution Channel ($ million) 10 Market Segmentation by Route of Administration 10.1 Market segments • Chart on Route of Administration - Market share 2025-2030 (%) • Data Table on Route of Administration - Market share 2025-2030 (%) 10.2 Comparison by Route of Administration • Chart on Comparison by Route of Administration • Data Table on Comparison by Route of Administration 10.3 Injectable - Market size and forecast 2025-2030 • Chart on Injectable - Market size and forecast 2025-2030 ($ million) • Data Table on Injectable - Market size and forecast 2025-2030 ($ million) • Chart on Injectable - Year-over-year growth 2025-2030 (%) • Data Table on Injectable - Year-over-year growth 2025-2030 (%) 10.4 Oral - Market size and forecast 2025-2030 • Chart on Oral - Market size and forecast 2025-2030 ($ million) • Data Table on Oral - Market size and forecast 2025-2030 ($ million) • Chart on Oral - Year-over-year growth 2025-2030 (%) • Data Table on Oral - Year-over-year growth 2025-2030 (%) 10.5 Topical - Market size and forecast 2025-2030 • Chart on Topical - Market size and forecast 2025-2030 ($ million) • Data Table on Topical - Market size and forecast 2025-2030 ($ million) • Chart on Topical - Year-over-year growth 2025-2030 (%) • Data Table on Topical - Year-over-year growth 2025-2030 (%) 10.6 Market opportunity by Route of Administration • Market opportunity by Route of Administration ($ million) • Data Table on Market opportunity by Route of Administration ($ million) 11 Market Segmentation by Drug Class 11.1 Market segments • Chart on Drug Class - Market share 2025-2030 (%) • Data Table on Drug Class - Market share 2025-2030 (%) 11.2 Comparison by Drug Class • Chart on Comparison by Drug Class • Data Table on Comparison by Drug Class 11.3 Biologics and biosimilars - Market size and forecast 2025-2030 • Chart on Biologics and biosimilars - Market size and forecast 2025-2030 ($ million) • Data Table on Biologics and biosimilars - Market size and forecast 2025-2030 ($ million) • Chart on Biologics and biosimilars - Year-over-year growth 2025-2030 (%) • Data Table on Biologics and biosimilars - Year-over-year growth 2025-2030 (%) 11.4 Small molecules and JAK inhibitors - Market size and forecast 2025-2030 • Chart on Small molecules and JAK inhibitors - Market size and forecast 2025-2030 ($ million) • Data Table on Small molecules and JAK inhibitors - Market size and forecast 2025-2030 ($ million) • Chart on Small molecules and JAK inhibitors - Year-over-year growth 2025-2030 (%) • Data Table on Small molecules and JAK inhibitors - Year-over-year growth 2025-2030 (%) 11.5 Immunosuppressants - Market size and forecast 2025-2030 • Chart on Immunosuppressants - Market size and forecast 2025-2030 ($ million) • Data Table on Immunosuppressants - Market size and forecast 2025-2030 ($ million) • Chart on Immunosuppressants - Year-over-year growth 2025-2030 (%) • Data Table on Immunosuppressants - Year-over-year growth 2025-2030 (%) 11.6 Corticosteroids and NSAIDs - Market size and forecast 2025-2030 • Chart on Corticosteroids and NSAIDs - Market size and forecast 2025-2030 ($ million) • Data Table on Corticosteroids and NSAIDs - Market size and forecast 2025-2030 ($ million) • Chart on Corticosteroids and NSAIDs - Year-over-year growth 2025-2030 (%) • Data Table on Corticosteroids and NSAIDs - Year-over-year growth 2025-2030 (%) 11.7 Interferons - Market size and forecast 2025-2030 • Chart on Interferons - Market size and forecast 2025-2030 ($ million) • Data Table on Interferons - Market size and forecast 2025-2030 ($ million) • Chart on Interferons - Year-over-year growth 2025-2030 (%) • Data Table on Interferons - Year-over-year growth 2025-2030 (%) 11.8 Market opportunity by Drug Class • Market opportunity by Drug Class ($ million) • Data Table on Market opportunity by Drug Class ($ million) 12 Customer Landscape 12.1 Customer landscape overview • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria 13 Geographic Landscape 13.1 Geographic segmentation • Chart on Market share by geography 2025-2030 (%) • Data Table on Market share by geography 2025-2030 (%) 13.2 Geographic comparison • Chart on Geographic comparison • Data Table on Geographic comparison 13.3 North America - Market size and forecast 2025-2030 • Chart on North America - Market size and forecast 2025-2030 ($ million) • Data Table on North America - Market size and forecast 2025-2030 ($ million) • Chart on North America - Year-over-year growth 2025-2030 (%) • Data Table on North America - Year-over-year growth 2025-2030 (%) • Chart on Regional Comparison - North America • Data Table on Regional Comparison - North America 13.3.1 US - Market size and forecast 2025-2030 • Chart on US - Market size and forecast 2025-2030 ($ million) • Data Table on US - Market size and forecast 2025-2030 ($ million) • Chart on US - Year-over-year growth 2025-2030 (%) • Data Table on US - Year-over-year growth 2025-2030 (%) 13.3.2 Canada - Market size and forecast 2025-2030 • Chart on Canada - Market size and forecast 2025-2030 ($ million) • Data Table on Canada - Market size and forecast 2025-2030 ($ million) • Chart on Canada - Year-over-year growth 2025-2030 (%) • Data Table on Canada - Year-over-year growth 2025-2030 (%) 13.3.3 Mexico - Market size and forecast 2025-2030 • Chart on Mexico - Market size and forecast 2025-2030 ($ million) • Data Table on Mexico - Market size and forecast 2025-2030 ($ million) • Chart on Mexico - Year-over-year growth 2025-2030 (%) • Data Table on Mexico - Year-over-year growth 2025-2030 (%) 13.4 Europe - Market size and forecast 2025-2030 • Chart on Europe - Market size and forecast 2025-2030 ($ million) • Data Table on Europe - Market size and forecast 2025-2030 ($ million) • Chart on Europe - Year-over-year growth 2025-2030 (%) • Data Table on Europe - Year-over-year growth 2025-2030 (%) • Chart on Regional Comparison - Europe • Data Table on Regional Comparison - Europe 13.4.1 Germany - Market size and forecast 2025-2030 • Chart on Germany - Market size and forecast 2025-2030 ($ million) • Data Table on Germany - Market size and forecast 2025-2030 ($ million) • Chart on Germany - Year-over-year growth 2025-2030 (%) • Data Table on Germany - Year-over-year growth 2025-2030 (%) 13.4.2 UK - Market size and forecast 2025-2030 • Chart on UK - Market size and forecast 2025-2030 ($ million) • Data Table on UK - Market size and forecast 2025-2030 ($ million) • Chart on UK - Year-over-year growth 2025-2030 (%) • Data Table on UK - Year-over-year growth 2025-2030 (%) 13.4.3 France - Market size and forecast 2025-2030 • Chart on France - Market size and forecast 2025-2030 ($ million) • Data Table on France - Market size and forecast 2025-2030 ($ million) • Chart on France - Year-over-year growth 2025-2030 (%) • Data Table on France - Year-over-year growth 2025-2030 (%) 13.4.4 Italy - Market size and forecast 2025-2030 • Chart on Italy - Market size and forecast 2025-2030 ($ million) • Data Table on Italy - Market size and forecast 2025-2030 ($ million) • Chart on Italy - Year-over-year growth 2025-2030 (%) • Data Table on Italy - Year-over-year growth 2025-2030 (%) 13.4.5 Spain - Market size and forecast 2025-2030 • Chart on Spain - Market size and forecast 2025-2030 ($ million) • Data Table on Spain - Market size and forecast 2025-2030 ($ million) • Chart on Spain - Year-over-year growth 2025-2030 (%) • Data Table on Spain - Year-over-year growth 2025-2030 (%) 13.4.6 The Netherlands - Market size and forecast 2025-2030 • Chart on The Netherlands - Market size and forecast 2025-2030 ($ million) • Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million) • Chart on The Netherlands - Year-over-year growth 2025-2030 (%) • Data Table on The Netherlands - Year-over-year growth 2025-2030 (%) 13.5 Asia - Market size and forecast 2025-2030 • Chart on Asia - Market size and forecast 2025-2030 ($ million) • Data Table on Asia - Market size and forecast 2025-2030 ($ million) • Chart on Asia - Year-over-year growth 2025-2030 (%) • Data Table on Asia - Year-over-year growth 2025-2030 (%) • Chart on Regional Comparison - Asia • Data Table on Regional Comparison - Asia 13.5.1 China - Market size and forecast 2025-2030 • Chart on China - Market size and forecast 2025-2030 ($ million) • Data Table on China - Market size and forecast 2025-2030 ($ million) • Chart on China - Year-over-year growth 2025-2030 (%) • Data Table on China - Year-over-year growth 2025-2030 (%) 13.5.2 India - Market size and forecast 2025-2030 • Chart on India - Market size and forecast 2025-2030 ($ million) • Data Table on India - Market size and forecast 2025-2030 ($ million) • Chart on India - Year-over-year growth 2025-2030 (%) • Data Table on India - Year-over-year growth 2025-2030 (%) 13.5.3 Japan - Market size and forecast 2025-2030 • Chart on Japan - Market size and forecast 2025-2030 ($ million) • Data Table on Japan - Market size and forecast 2025-2030 ($ million) • Chart on Japan - Year-over-year growth 2025-2030 (%) • Data Table on Japan - Year-over-year growth 2025-2030 (%) 13.5.4 South Korea - Market size and forecast 2025-2030 • Chart on South Korea - Market size and forecast 2025-2030 ($ million) • Data Table on South Korea - Market size and forecast 2025-2030 ($ million) • Chart on South Korea - Year-over-year growth 2025-2030 (%) • Data Table on South Korea - Year-over-year growth 2025-2030 (%) 13.5.5 Indonesia - Market size and forecast 2025-2030 • Chart on Indonesia - Market size and forecast 2025-2030 ($ million) • Data Table on Indonesia - Market size and forecast 2025-2030 ($ million) • Chart on Indonesia - Year-over-year growth 2025-2030 (%) • Data Table on Indonesia - Year-over-year growth 2025-2030 (%) 13.5.6 Thailand - Market size and forecast 2025-2030 • Chart on Thailand - Market size and forecast 2025-2030 ($ million) • Data Table on Thailand - Market size and forecast 2025-2030 ($ million) • Chart on Thailand - Year-over-year growth 2025-2030 (%) • Data Table on Thailand - Year-over-year growth 2025-2030 (%) 13.6 Rest of World (ROW) - Market size and forecast 2025-2030 • Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million) • Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million) • Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%) • Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%) • Chart on Regional Comparison - Rest of World (ROW) • Data Table on Regional Comparison - Rest of World (ROW) 13.6.1 Brazil - Market size and forecast 2025-2030 • Chart on Brazil - Market size and forecast 2025-2030 ($ million) • Data Table on Brazil - Market size and forecast 2025-2030 ($ million) • Chart on Brazil - Year-over-year growth 2025-2030 (%) • Data Table on Brazil - Year-over-year growth 2025-2030 (%) 13.6.2 Saudi Arabia - Market size and forecast 2025-2030 • Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million) • Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million) • Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%) • Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%) 13.6.3 UAE - Market size and forecast 2025-2030 • Chart on UAE - Market size and forecast 2025-2030 ($ million) • Data Table on UAE - Market size and forecast 2025-2030 ($ million) • Chart on UAE - Year-over-year growth 2025-2030 (%) • Data Table on UAE - Year-over-year growth 2025-2030 (%) 13.6.4 Turkey - Market size and forecast 2025-2030 • Chart on Turkey - Market size and forecast 2025-2030 ($ million) • Data Table on Turkey - Market size and forecast 2025-2030 ($ million) • Chart on Turkey - Year-over-year growth 2025-2030 (%) • Data Table on Turkey - Year-over-year growth 2025-2030 (%) 13.6.5 Argentina - Market size and forecast 2025-2030 • Chart on Argentina - Market size and forecast 2025-2030 ($ million) • Data Table on Argentina - Market size and forecast 2025-2030 ($ million) • Chart on Argentina - Year-over-year growth 2025-2030 (%) • Data Table on Argentina - Year-over-year growth 2025-2030 (%) 13.6.6 Colombia - Market size and forecast 2025-2030 • Chart on Colombia - Market size and forecast 2025-2030 ($ million) • Data Table on Colombia - Market size and forecast 2025-2030 ($ million) • Chart on Colombia - Year-over-year growth 2025-2030 (%) • Data Table on Colombia - Year-over-year growth 2025-2030 (%) 13.6.7 South Africa - Market size and forecast 2025-2030 • Chart on South Africa - Market size and forecast 2025-2030 ($ million) • Data Table on South Africa - Market size and forecast 2025-2030 ($ million) • Chart on South Africa - Year-over-year growth 2025-2030 (%) • Data Table on South Africa - Year-over-year growth 2025-2030 (%) 13.6.8 Israel - Market size and forecast 2025-2030 • Chart on Israel - Market size and forecast 2025-2030 ($ million) • Data Table on Israel - Market size and forecast 2025-2030 ($ million) • Chart on Israel - Year-over-year growth 2025-2030 (%) • Data Table on Israel - Year-over-year growth 2025-2030 (%) 13.7 Market opportunity by geography • Market opportunity by geography ($ million) • Data Tables on Market opportunity by geography ($ million) 14 Drivers, Challenges, and Opportunity 14.1 Market drivers • Rising prevalence of autoimmune disorders and increased diagnostic capabilities • Transition toward precision-targeted biologics and advanced monoclonal antibodies • Proliferation of biosimilars and favorable regulatory frameworks 14.2 Market challenges • Exorbitant treatment costs and severe reimbursement constraints • Complex manufacturing requirements and vulnerable global supply chains • Stringent regulatory hurdles and patent cliff pressures 14.3 Impact of drivers and challenges • Impact of drivers and challenges in 2025 and 2030 14.4 Market opportunities • Integration of AI and ML in drug discovery • Expansion of subcutaneous delivery systems and self-administered formulations • Accelerated penetration of biosimilars across emerging and developed geographies 15 Competitive Landscape 15.1 Overview 15.2 Competitive Landscape • Overview on criticality of inputs and factors of differentiation 15.3 Landscape disruption • Overview on factors of disruption 15.4 Industry risks • Impact of key risks on business 16 Competitive Analysis 16.1 Companies profiled • Companies covered 16.2 Company ranking index • Company ranking index 16.3 Market positioning of companies • Matrix on companies position and classification 16.4 AbbVie Inc. • AbbVie Inc. - Overview • AbbVie Inc. - Business segments • AbbVie Inc. - Key news • AbbVie Inc. - Key offerings • AbbVie Inc. - Segment focus • SWOT 16.5 Amgen Inc. • Amgen Inc. - Overview • Amgen Inc. - Product / Service • Amgen Inc. - Key news • Amgen Inc. - Key offerings • SWOT 16.6 AstraZeneca Plc • AstraZeneca Plc - Overview • AstraZeneca Plc - Business segments • AstraZeneca Plc - Key news • AstraZeneca Plc - Key offerings • AstraZeneca Plc - Segment focus • SWOT 16.7 Bayer AG • Bayer AG - Overview • Bayer AG - Business segments • Bayer AG - Key news • Bayer AG - Key offerings • Bayer AG - Segment focus • SWOT 16.8 Bristol Myers Squibb Co. • Bristol Myers Squibb Co. - Overview • Bristol Myers Squibb Co. - Product / Service • Bristol Myers Squibb Co. - Key news • Bristol Myers Squibb Co. - Key offerings • SWOT 16.9 Eli Lilly and Co. • Eli Lilly and Co. - Overview • Eli Lilly and Co. - Product / Service • Eli Lilly and Co. - Key news • Eli Lilly and Co. - Key offerings • SWOT 16.10 F. Hoffmann La Roche Ltd. • F. Hoffmann La Roche Ltd. - Overview • F. Hoffmann La Roche Ltd. - Business segments • F. Hoffmann La Roche Ltd. - Key news • F. Hoffmann La Roche Ltd. - Key offerings • F. Hoffmann La Roche Ltd. - Segment focus • SWOT 16.11 Gilead Sciences Inc. • Gilead Sciences Inc. - Overview • Gilead Sciences Inc. - Business segments • Gilead Sciences Inc. - Key news • Gilead Sciences Inc. - Key offerings • Gilead Sciences Inc. - Segment focus • SWOT 16.12 GlaxoSmithKline Plc • GlaxoSmithKline Plc - Overview • GlaxoSmithKline Plc - Business segments • GlaxoSmithKline Plc - Key news • GlaxoSmithKline Plc - Key offerings • GlaxoSmithKline Plc - Segment focus • SWOT 16.13 Johnson and Johnson • Johnson and Johnson - Overview • Johnson and Johnson - Business segments • Johnson and Johnson - Key news • Johnson and Johnson - Key offerings • Johnson and Johnson - Segment focus • SWOT 16.14 Merck KGaA • Merck KGaA - Overview • Merck KGaA - Business segments • Merck KGaA - Key news • Merck KGaA - Key offerings • Merck KGaA - Segment focus • SWOT 16.15 Novartis AG • Novartis AG - Overview • Novartis AG - Business segments • Novartis AG - Key news • Novartis AG - Key offerings • Novartis AG - Segment focus • SWOT 16.16 Pfizer Inc. • Pfizer Inc. - Overview • Pfizer Inc. - Business segments • Pfizer Inc. - Key news • Pfizer Inc. - Key offerings • Pfizer Inc. - Segment focus • SWOT 16.17 Sanofi SA • Sanofi SA - Overview • Sanofi SA - Business segments • Sanofi SA - Key news • Sanofi SA - Key offerings • Sanofi SA - Segment focus • SWOT 16.18 Takeda Pharmaceutical Ltd. • Takeda Pharmaceutical Ltd. - Overview • Takeda Pharmaceutical Ltd. - Business segments • Takeda Pharmaceutical Ltd. - Key news • Takeda Pharmaceutical Ltd. - Key offerings • Takeda Pharmaceutical Ltd. - Segment focus • SWOT 17 Appendix 17.1 Scope of the report • Market definition • Objectives • Notes and caveats 17.2 Inclusions and exclusions checklist • Inclusions checklist • Exclusions checklist 17.3 Currency conversion rates for US$ • Currency conversion rates for US$ 17.4 Research methodology • Research methodology 17.5 Data procurement • Information sources 17.6 Data validation • Data validation 17.7 Validation techniques employed for market sizing • Validation techniques employed for market sizing 17.8 Data synthesis • Data synthesis 17.9 360 degree market analysis • 360 degree market analysis 17.10 List of abbreviations • List of abbreviations List of Tables/GraphsExhibits1: Executive Summary - Chart on Market OverviewExhibits2: Executive Summary - Data Table on Market Overview Exhibits3: Executive Summary - Chart on Global Market Characteristics Exhibits4: Executive Summary - Chart on Market by Geography Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy Area Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel Exhibits7: Executive Summary - Chart on Market Segmentation by Route of Administration Exhibits8: Executive Summary - Chart on Market Segmentation by Drug Class Exhibits9: Executive Summary - Chart on Incremental Growth Exhibits10: Executive Summary - Data Table on Incremental Growth Exhibits11: Executive Summary - Chart on Company Market Positioning Exhibits12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits13: Chart on Overview on criticality of inputs and factors of differentiation Exhibits14: Chart on Overview on factors of disruption Exhibits15: Chart on Impact of drivers and challenges in 2025 and 2030 Exhibits16: Chart on Parent Market Exhibits17: Data Table on - Parent Market Exhibits18: Chart on Market characteristics analysis Exhibits19: Chart on Value chain analysis Exhibits20: Data Table on Offerings of companies included in the market definition Exhibits21: Market segments Exhibits22: Chart on Global - Market size and forecast 2025-2030 ($ million) Exhibits23: Data Table on Global - Market size and forecast 2025-2030 ($ million) Exhibits24: Chart on Global Market: Year-over-year growth 2025-2030 (%) Exhibits25: Data Table on Global Market: Year-over-year growth 2025-2030 (%) Exhibits26: Historic Market Size - Data Table on Global Autoimmune Drugs Market 2020 - 2024 ($ million) Exhibits27: Historic Market Size - Therapy Area Segment 2020 - 2024 ($ million) Exhibits28: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million) Exhibits29: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million) Exhibits30: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million) Exhibits31: Historic Market Size - Geography Segment 2020 - 2024 ($ million) Exhibits32: Historic Market Size - Country Segment 2020 - 2024 ($ million) Exhibits33: Five forces analysis - Comparison between 2025 and 2030 Exhibits34: Bargaining power of buyers - Impact of key factors 2025 and 2030 Exhibits35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030 Exhibits36: Threat of new entrants - Impact of key factors in 2025 and 2030 Exhibits37: Threat of substitutes - Impact of key factors in 2025 and 2030 Exhibits38: Threat of rivalry - Impact of key factors in 2025 and 2030 Exhibits39: Chart on Market condition - Five forces 2025 and 2030 Exhibits40: Chart on Therapy Area - Market share 2025-2030 (%) Exhibits41: Data Table on Therapy Area - Market share 2025-2030 (%) Exhibits42: Chart on Comparison by Therapy Area Exhibits43: Data Table on Comparison by Therapy Area Exhibits44: Chart on Rheumatoid arthritis - Market size and forecast 2025-2030 ($ million) Exhibits45: Data Table on Rheumatoid arthritis - Market size and forecast 2025-2030 ($ million) Exhibits46: Chart on Rheumatoid arthritis - Year-over-year growth 2025-2030 (%) Exhibits47: Data Table on Rheumatoid arthritis - Year-over-year growth 2025-2030 (%) Exhibits48: Chart on Multiple sclerosis - Market size and forecast 2025-2030 ($ million) Exhibits49: Data Table on Multiple sclerosis - Market size and forecast 2025-2030 ($ million) Exhibits50: Chart on Multiple sclerosis - Year-over-year growth 2025-2030 (%) Exhibits51: Data Table on Multiple sclerosis - Year-over-year growth 2025-2030 (%) Exhibits52: Chart on Psoriasis - Market size and forecast 2025-2030 ($ million) Exhibits53: Data Table on Psoriasis - Market size and forecast 2025-2030 ($ million) Exhibits54: Chart on Psoriasis - Year-over-year growth 2025-2030 (%) Exhibits55: Data Table on Psoriasis - Year-over-year growth 2025-2030 (%) Exhibits56: Chart on Inflammatory bowel disease - Market size and forecast 2025-2030 ($ million) Exhibits57: Data Table on Inflammatory bowel disease - Market size and forecast 2025-2030 ($ million) Exhibits58: Chart on Inflammatory bowel disease - Year-over-year growth 2025-2030 (%) Exhibits59: Data Table on Inflammatory bowel disease - Year-over-year growth 2025-2030 (%) Exhibits60: Chart on Others - Market size and forecast 2025-2030 ($ million) Exhibits61: Data Table on Others - Market size and forecast 2025-2030 ($ million) Exhibits62: Chart on Others - Year-over-year growth 2025-2030 (%) Exhibits63: Data Table on Others - Year-over-year growth 2025-2030 (%) Exhibits64: Market opportunity by Therapy Area ($ million) Exhibits65: Data Table on Market opportunity by Therapy Area ($ million) Exhibits66: Chart on Distribution Channel - Market share 2025-2030 (%) Exhibits67: Data Table on Distribution Channel - Market share 2025-2030 (%) Exhibits68: Chart on Comparison by Distribution Channel Exhibits69: Data Table on Comparison by Distribution Channel Exhibits70: Chart on Hospital - Market size and forecast 2025-2030 ($ million) Exhibits71: Data Table on Hospital - Market size and forecast 2025-2030 ($ million) Exhibits72: Chart on Hospital - Year-over-year growth 2025-2030 (%) Exhibits73: Data Table on Hospital - Year-over-year growth 2025-2030 (%) Exhibits74: Chart on Pharmacy - Market size and forecast 2025-2030 ($ million) Exhibits75: Data Table on Pharmacy - Market size and forecast 2025-2030 ($ million) Exhibits76: Chart on Pharmacy - Year-over-year growth 2025-2030 (%) Exhibits77: Data Table on Pharmacy - Year-over-year growth 2025-2030 (%) Exhibits78: Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million) Exhibits79: Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million) Exhibits80: Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%) Exhibits81: Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%) Exhibits82: Chart on Online - Market size and forecast 2025-2030 ($ million) Exhibits83: Data Table on Online - Market size and forecast 2025-2030 ($ million) Exhibits84: Chart on Online - Year-over-year growth 2025-2030 (%) Exhibits85: Data Table on Online - Year-over-year growth 2025-2030 (%) Exhibits86: Market opportunity by Distribution Channel ($ million) Exhibits87: Data Table on Market opportunity by Distribution Channel ($ million) Exhibits88: Chart on Route of Administration - Market share 2025-2030 (%) Exhibits89: Data Table on Route of Administration - Market share 2025-2030 (%) Exhibits90: Chart on Comparison by Route of Administration Exhibits91: Data Table on Comparison by Route of Administration Exhibits92: Chart on Injectable - Market size and forecast 2025-2030 ($ million) Exhibits93: Data Table on Injectable - Market size and forecast 2025-2030 ($ million) Exhibits94: Chart on Injectable - Year-over-year growth 2025-2030 (%) Exhibits95: Data Table on Injectable - Year-over-year growth 2025-2030 (%) Exhibits96: Chart on Oral - Market size and forecast 2025-2030 ($ million) Exhibits97: Data Table on Oral - Market size and forecast 2025-2030 ($ million) Exhibits98: Chart on Oral - Year-over-year growth 2025-2030 (%) Exhibits99: Data Table on Oral - Year-over-year growth 2025-2030 (%) Exhibits100: Chart on Topical - Market size and forecast 2025-2030 ($ million) Exhibits101: Data Table on Topical - Market size and forecast 2025-2030 ($ million) Exhibits102: Chart on Topical - Year-over-year growth 2025-2030 (%) Exhibits103: Data Table on Topical - Year-over-year growth 2025-2030 (%) Exhibits104: Market opportunity by Route of Administration ($ million) Exhibits105: Data Table on Market opportunity by Route of Administration ($ million) Exhibits106: Chart on Drug Class - Market share 2025-2030 (%) Exhibits107: Data Table on Drug Class - Market share 2025-2030 (%) Exhibits108: Chart on Comparison by Drug Class Exhibits109: Data Table on Comparison by Drug Class Exhibits110: Chart on Biologics and biosimilars - Market size and forecast 2025-2030 ($ million) Exhibits111: Data Table on Biologics and biosimilars - Market size and forecast 2025-2030 ($ million) Exhibits112: Chart on Biologics and biosimilars - Year-over-year growth 2025-2030 (%) Exhibits113: Data Table on Biologics and biosimilars - Year-over-year growth 2025-2030 (%) Exhibits114: Chart on Small molecules and JAK inhibitors - Market size and forecast 2025-2030 ($ million) Exhibits115: Data Table on Small molecules and JAK inhibitors - Market size and forecast 2025-2030 ($ million) Exhibits116: Chart on Small molecules and JAK inhibitors - Year-over-year growth 2025-2030 (%) Exhibits117: Data Table on Small molecules and JAK inhibitors - Year-over-year growth 2025-2030 (%) Exhibits118: Chart on Immunosuppressants - Market size and forecast 2025-2030 ($ million) Exhibits119: Data Table on Immunosuppressants - Market size and forecast 2025-2030 ($ million) Exhibits120: Chart on Immunosuppressants - Year-over-year growth 2025-2030 (%) Exhibits121: Data Table on Immunosuppressants - Year-over-year growth 2025-2030 (%) Exhibits122: Chart on Corticosteroids and NSAIDs - Market size and forecast 2025-2030 ($ million) Exhibits123: Data Table on Corticosteroids and NSAIDs - Market size and forecast 2025-2030 ($ million) Exhibits124: Chart on Corticosteroids and NSAIDs - Year-over-year growth 2025-2030 (%) Exhibits125: Data Table on Corticosteroids and NSAIDs - Year-over-year growth 2025-2030 (%) Exhibits126: Chart on Interferons - Market size and forecast 2025-2030 ($ million) Exhibits127: Data Table on Interferons - Market size and forecast 2025-2030 ($ million) Exhibits128: Chart on Interferons - Year-over-year growth 2025-2030 (%) Exhibits129: Data Table on Interferons - Year-over-year growth 2025-2030 (%) Exhibits130: Market opportunity by Drug Class ($ million) Exhibits131: Data Table on Market opportunity by Drug Class ($ million) Exhibits132: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits133: Chart on Market share by geography 2025-2030 (%) Exhibits134: Data Table on Market share by geography 2025-2030 (%) Exhibits135: Chart on Geographic comparison Exhibits136: Data Table on Geographic comparison Exhibits137: Chart on North America - Market size and forecast 2025-2030 ($ million) Exhibits138: Data Table on North America - Market size and forecast 2025-2030 ($ million) Exhibits139: Chart on North America - Year-over-year growth 2025-2030 (%) Exhibits140: Data Table on North America - Year-over-year growth 2025-2030 (%) Exhibits141: Chart on Regional Comparison - North America Exhibits142: Data Table on Regional Comparison - North America Exhibits143: Chart on US - Market size and forecast 2025-2030 ($ million) Exhibits144: Data Table on US - Market size and forecast 2025-2030 ($ million) Exhibits145: Chart on US - Year-over-year growth 2025-2030 (%) Exhibits146: Data Table on US - Year-over-year growth 2025-2030 (%) Exhibits147: Chart on Canada - Market size and forecast 2025-2030 ($ million) Exhibits148: Data Table on Canada - Market size and forecast 2025-2030 ($ million) Exhibits149: Chart on Canada - Year-over-year growth 2025-2030 (%) Exhibits150: Data Table on Canada - Year-over-year growth 2025-2030 (%) Exhibits151: Chart on Mexico - Market size and forecast 2025-2030 ($ million) Exhibits152: Data Table on Mexico - Market size and forecast 2025-2030 ($ million) Exhibits153: Chart on Mexico - Year-over-year growth 2025-2030 (%) Exhibits154: Data Table on Mexico - Year-over-year growth 2025-2030 (%) Exhibits155: Chart on Europe - Market size and forecast 2025-2030 ($ million) Exhibits156: Data Table on Europe - Market size and forecast 2025-2030 ($ million) Exhibits157: Chart on Europe - Year-over-year growth 2025-2030 (%) Exhibits158: Data Table on Europe - Year-over-year growth 2025-2030 (%) Exhibits159: Chart on Regional Comparison - Europe Exhibits160: Data Table on Regional Comparison - Europe Exhibits161: Chart on Germany - Market size and forecast 2025-2030 ($ million) Exhibits162: Data Table on Germany - Market size and forecast 2025-2030 ($ million) Exhibits163: Chart on Germany - Year-over-year growth 2025-2030 (%) Exhibits164: Data Table on Germany - Year-over-year growth 2025-2030 (%) Exhibits165: Chart on UK - Market size and forecast 2025-2030 ($ million) Exhibits166: Data Table on UK - Market size and forecast 2025-2030 ($ million) Exhibits167: Chart on UK - Year-over-year growth 2025-2030 (%) Exhibits168: Data Table on UK - Year-over-year growth 2025-2030 (%) Exhibits169: Chart on France - Market size and forecast 2025-2030 ($ million) Exhibits170: Data Table on France - Market size and forecast 2025-2030 ($ million) Exhibits171: Chart on France - Year-over-year growth 2025-2030 (%) Exhibits172: Data Table on France - Year-over-year growth 2025-2030 (%) Exhibits173: Chart on Italy - Market size and forecast 2025-2030 ($ million) Exhibits174: Data Table on Italy - Market size and forecast 2025-2030 ($ million) Exhibits175: Chart on Italy - Year-over-year growth 2025-2030 (%) Exhibits176: Data Table on Italy - Year-over-year growth 2025-2030 (%) Exhibits177: Chart on Spain - Market size and forecast 2025-2030 ($ million) Exhibits178: Data Table on Spain - Market size and forecast 2025-2030 ($ million) Exhibits179: Chart on Spain - Year-over-year growth 2025-2030 (%) Exhibits180: Data Table on Spain - Year-over-year growth 2025-2030 (%) Exhibits181: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million) Exhibits182: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million) Exhibits183: Chart on The Netherlands - Year-over-year growth 2025-2030 (%) Exhibits184: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%) Exhibits185: Chart on Asia - Market size and forecast 2025-2030 ($ million) Exhibits186: Data Table on Asia - Market size and forecast 2025-2030 ($ million) Exhibits187: Chart on Asia - Year-over-year growth 2025-2030 (%) Exhibits188: Data Table on Asia - Year-over-year growth 2025-2030 (%) Exhibits189: Chart on Regional Comparison - Asia Exhibits190: Data Table on Regional Comparison - Asia Exhibits191: Chart on China - Market size and forecast 2025-2030 ($ million) Exhibits192: Data Table on China - Market size and forecast 2025-2030 ($ million) Exhibits193: Chart on China - Year-over-year growth 2025-2030 (%) Exhibits194: Data Table on China - Year-over-year growth 2025-2030 (%) Exhibits195: Chart on India - Market size and forecast 2025-2030 ($ million) Exhibits196: Data Table on India - Market size and forecast 2025-2030 ($ million) Exhibits197: Chart on India - Year-over-year growth 2025-2030 (%) Exhibits198: Data Table on India - Year-over-year growth 2025-2030 (%) Exhibits199: Chart on Japan - Market size and forecast 2025-2030 ($ million) Exhibits200: Data Table on Japan - Market size and forecast 2025-2030 ($ million) Exhibits201: Chart on Japan - Year-over-year growth 2025-2030 (%) Exhibits202: Data Table on Japan - Year-over-year growth 2025-2030 (%) Exhibits203: Chart on South Korea - Market size and forecast 2025-2030 ($ million) Exhibits204: Data Table on South Korea - Market size and forecast 2025-2030 ($ million) Exhibits205: Chart on South Korea - Year-over-year growth 2025-2030 (%) Exhibits206: Data Table on South Korea - Year-over-year growth 2025-2030 (%) Exhibits207: Chart on Indonesia - Market size and forecast 2025-2030 ($ million) Exhibits208: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million) Exhibits209: Chart on Indonesia - Year-over-year growth 2025-2030 (%) Exhibits210: Data Table on Indonesia - Year-over-year growth 2025-2030 (%) Exhibits211: Chart on Thailand - Market size and forecast 2025-2030 ($ million) Exhibits212: Data Table on Thailand - Market size and forecast 2025-2030 ($ million) Exhibits213: Chart on Thailand - Year-over-year growth 2025-2030 (%) Exhibits214: Data Table on Thailand - Year-over-year growth 2025-2030 (%) Exhibits215: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million) Exhibits216: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million) Exhibits217: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%) Exhibits218: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%) Exhibits219: Chart on Regional Comparison - Rest of World (ROW) Exhibits220: Data Table on Regional Comparison - Rest of World (ROW) Exhibits221: Chart on Brazil - Market size and forecast 2025-2030 ($ million) Exhibits222: Data Table on Brazil - Market size and forecast 2025-2030 ($ million) Exhibits223: Chart on Brazil - Year-over-year growth 2025-2030 (%) Exhibits224: Data Table on Brazil - Year-over-year growth 2025-2030 (%) Exhibits225: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million) Exhibits226: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million) Exhibits227: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%) Exhibits228: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%) Exhibits229: Chart on UAE - Market size and forecast 2025-2030 ($ million) Exhibits230: Data Table on UAE - Market size and forecast 2025-2030 ($ million) Exhibits231: Chart on UAE - Year-over-year growth 2025-2030 (%) Exhibits232: Data Table on UAE - Year-over-year growth 2025-2030 (%) Exhibits233: Chart on Turkey - Market size and forecast 2025-2030 ($ million) Exhibits234: Data Table on Turkey - Market size and forecast 2025-2030 ($ million) Exhibits235: Chart on Turkey - Year-over-year growth 2025-2030 (%) Exhibits236: Data Table on Turkey - Year-over-year growth 2025-2030 (%) Exhibits237: Chart on Argentina - Market size and forecast 2025-2030 ($ million) Exhibits238: Data Table on Argentina - Market size and forecast 2025-2030 ($ million) Exhibits239: Chart on Argentina - Year-over-year growth 2025-2030 (%) Exhibits240: Data Table on Argentina - Year-over-year growth 2025-2030 (%) Exhibits241: Chart on Colombia - Market size and forecast 2025-2030 ($ million) Exhibits242: Data Table on Colombia - Market size and forecast 2025-2030 ($ million) Exhibits243: Chart on Colombia - Year-over-year growth 2025-2030 (%) Exhibits244: Data Table on Colombia - Year-over-year growth 2025-2030 (%) Exhibits245: Chart on South Africa - Market size and forecast 2025-2030 ($ million) Exhibits246: Data Table on South Africa - Market size and forecast 2025-2030 ($ million) Exhibits247: Chart on South Africa - Year-over-year growth 2025-2030 (%) Exhibits248: Data Table on South Africa - Year-over-year growth 2025-2030 (%) Exhibits249: Chart on Israel - Market size and forecast 2025-2030 ($ million) Exhibits250: Data Table on Israel - Market size and forecast 2025-2030 ($ million) Exhibits251: Chart on Israel - Year-over-year growth 2025-2030 (%) Exhibits252: Data Table on Israel - Year-over-year growth 2025-2030 (%) Exhibits253: Market opportunity by geography ($ million) Exhibits254: Data Tables on Market opportunity by geography ($ million) Exhibits255: Impact of drivers and challenges in 2025 and 2030 Exhibits256: Overview on criticality of inputs and factors of differentiation Exhibits257: Overview on factors of disruption Exhibits258: Impact of key risks on business Exhibits259: Companies covered Exhibits260: Company ranking index Exhibits261: Matrix on companies position and classification Exhibits262: AbbVie Inc. - Overview Exhibits263: AbbVie Inc. - Business segments Exhibits264: AbbVie Inc. - Key news Exhibits265: AbbVie Inc. - Key offerings Exhibits266: AbbVie Inc. - Segment focus Exhibits267: SWOT Exhibits268: Amgen Inc. - Overview Exhibits269: Amgen Inc. - Product / Service Exhibits270: Amgen Inc. - Key news Exhibits271: Amgen Inc. - Key offerings Exhibits272: SWOT Exhibits273: AstraZeneca Plc - Overview Exhibits274: AstraZeneca Plc - Business segments Exhibits275: AstraZeneca Plc - Key news Exhibits276: AstraZeneca Plc - Key offerings Exhibits277: AstraZeneca Plc - Segment focus Exhibits278: SWOT Exhibits279: Bayer AG - Overview Exhibits280: Bayer AG - Business segments Exhibits281: Bayer AG - Key news Exhibits282: Bayer AG - Key offerings Exhibits283: Bayer AG - Segment focus Exhibits284: SWOT Exhibits285: Bristol Myers Squibb Co. - Overview Exhibits286: Bristol Myers Squibb Co. - Product / Service Exhibits287: Bristol Myers Squibb Co. - Key news Exhibits288: Bristol Myers Squibb Co. - Key offerings Exhibits289: SWOT Exhibits290: Eli Lilly and Co. - Overview Exhibits291: Eli Lilly and Co. - Product / Service Exhibits292: Eli Lilly and Co. - Key news Exhibits293: Eli Lilly and Co. - Key offerings Exhibits294: SWOT Exhibits295: F. Hoffmann La Roche Ltd. - Overview Exhibits296: F. Hoffmann La Roche Ltd. - Business segments Exhibits297: F. Hoffmann La Roche Ltd. - Key news Exhibits298: F. Hoffmann La Roche Ltd. - Key offerings Exhibits299: F. Hoffmann La Roche Ltd. - Segment focus Exhibits300: SWOT Exhibits301: Gilead Sciences Inc. - Overview Exhibits302: Gilead Sciences Inc. - Business segments Exhibits303: Gilead Sciences Inc. - Key news Exhibits304: Gilead Sciences Inc. - Key offerings Exhibits305: Gilead Sciences Inc. - Segment focus Exhibits306: SWOT Exhibits307: GlaxoSmithKline Plc - Overview Exhibits308: GlaxoSmithKline Plc - Business segments Exhibits309: GlaxoSmithKline Plc - Key news Exhibits310: GlaxoSmithKline Plc - Key offerings Exhibits311: GlaxoSmithKline Plc - Segment focus Exhibits312: SWOT Exhibits313: Johnson and Johnson - Overview Exhibits314: Johnson and Johnson - Business segments Exhibits315: Johnson and Johnson - Key news Exhibits316: Johnson and Johnson - Key offerings Exhibits317: Johnson and Johnson - Segment focus Exhibits318: SWOT Exhibits319: Merck KGaA - Overview Exhibits320: Merck KGaA - Business segments Exhibits321: Merck KGaA - Key news Exhibits322: Merck KGaA - Key offerings Exhibits323: Merck KGaA - Segment focus Exhibits324: SWOT Exhibits325: Novartis AG - Overview Exhibits326: Novartis AG - Business segments Exhibits327: Novartis AG - Key news Exhibits328: Novartis AG - Key offerings Exhibits329: Novartis AG - Segment focus Exhibits330: SWOT Exhibits331: Pfizer Inc. - Overview Exhibits332: Pfizer Inc. - Business segments Exhibits333: Pfizer Inc. - Key news Exhibits334: Pfizer Inc. - Key offerings Exhibits335: Pfizer Inc. - Segment focus Exhibits336: SWOT Exhibits337: Sanofi SA - Overview Exhibits338: Sanofi SA - Business segments Exhibits339: Sanofi SA - Key news Exhibits340: Sanofi SA - Key offerings Exhibits341: Sanofi SA - Segment focus Exhibits342: SWOT Exhibits343: Takeda Pharmaceutical Ltd. - Overview Exhibits344: Takeda Pharmaceutical Ltd. - Business segments Exhibits345: Takeda Pharmaceutical Ltd. - Key news Exhibits346: Takeda Pharmaceutical Ltd. - Key offerings Exhibits347: Takeda Pharmaceutical Ltd. - Segment focus Exhibits348: SWOT Exhibits349: Inclusions checklist Exhibits350: Exclusions checklist Exhibits351: Currency conversion rates for US$ Exhibits352: Research methodology Exhibits353: Information sources Exhibits354: Data validation Exhibits355: Validation techniques employed for market sizing Exhibits356: Data synthesis Exhibits357: 360 degree market analysis Exhibits358: List of abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
TechNavio社の Health Care分野 での最新刊レポート
よくあるご質問TechNavio社はどのような調査会社ですか?テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
